Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Evelo Biosciences, Inc. (EVLO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K8-K10-K10-K
Revenues  0.00.00.00.00.039.90.00.0
Cost of goods sold  0.00.00.00.00.079.80.00.0
Gross profit  0.00.00.00.00.0-39.90.00.0
            Gross margin       -100.0%  
Selling, general and administrative   [+]29.931.822.323.218.218.27.63.9
Research and development  78.683.669.663.139.9 20.09.1
EBITDA   [+]-106.4-113.2-89.9-84.6-56.2 -26.7-12.5
            EBITDA margin       -145.7%  
Depreciation and amortization  2.12.22.01.81.9 0.80.5
EBIT   [+]-108.5-115.4-91.9-86.4-58.1-58.1-27.5-13.0
            EBIT margin       -145.7%  
Interest income, net   [+]4.73.62.11.01.6 0.20.3
Other income (expense), net   [+]-9.8-10.0-3.50.0-0.41.2-0.7-0.3
Pre-tax income  -113.6-121.7-93.3-85.3-56.9-56.9-28.0-13.3
Income taxes  0.90.40.40.20.00.00.00.0
            Tax rate      0.0%0.0%0.0%0.0%
Net income  -114.5-122.2-93.7-85.5-60.9-60.9-34.1-15.0
            Net margin       -152.6%  
   
Basic EPS   [+]($1.31)($2.31)($2.37)($2.67)($2.78)($2.78)($9.10)($5.28)
Diluted EPS   [+]($1.31)($2.31)($2.37)($2.67)($2.78)($2.78)($9.10)($5.28)
   
Shares outstanding (basic)   [+]87.252.939.532.021.921.93.82.8
Shares outstanding (diluted)   [+]87.252.939.532.021.921.93.82.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy